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Objective: With improving rates of initial survival in severe sepsis, second-hit infections
that occur following resolution of the primary insult carry an increasing burden of
morbidity. However, despite the clinical relevance of these infections, no data are available
on differential outcomes in patients with first and second-hit infections depending on the
nature of the causative organism. This study aims to explore any differences in these
subgroups.
Design: In a retrospective, observational cohort study, the United Kingdom Intensive
Care National Audit & Research Centre (ICNARC) database was used to explore the
outcomes of patient with first-hit infections leading to sepsis, and sepsis patients with
second-hit infections grouped according to the Gram status of the causative organism.
Setting: General critical care units in England, Wales, and Northern Ireland participating
in the ICNARC programme between 1 January, 2007 and 30 June, 2012.
Patients: Patient groups analyzed included 2119 patients with and 1319 patients
without sepsis who developed an intensive care unit acquired infection in blood.
Subgroups included patients with trauma, emergency neurosurgery, elective surgery, and
cardiogenic shock.
Measurements and main results: Gram-negative organisms were associated with
poorer outcomes in first-hit infections. The 90-day mortality of patients who developed
a Gram-negative infection was 43.6% following elective surgery and 27.9% following
trauma. This compared with a mortality of 25.6 and 20.6%, respectively, in Gram-positive
infections. Unexpectedly, an inverse relationship between Gram status and mortality
was observed in second-hit infections. Patients with an initial diagnosis of sepsis who
developed secondary infections caused by Gram-negative organisms had a 90-day
mortality of 40.4%, compared with 43.6% in Gram-positive infections.
Conclusions: Our study identifies a fundamental difference in patient outcomes
between first-hit and second-hit bacterial infections, which may be due to genetic,
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microbiological, immunological, and environmental factors. This finding has direct
implications for risk stratification and defines future research priorities.
Keywords: sepsis, bacterial infections, intensive care, Gram-positive bacterial infections, Gram-negative bacterial
infections
INTRODUCTION
Measured using any chosen metric, sepsis is a devastating
condition for patients, their families, and society as a whole
(Bryce et al., 2005; Newton et al., 2014). It accounts for 15–20%
of all deaths in the developing world and kills over 1.5 million
newborns and children every year (Bryce et al., 2005; Stevenson
et al., 2014). As a medical condition, it is more deadly than stroke,
killing a third of all patients with the severe form of the illness
(Angus et al., 2001; Stevenson et al., 2014). It is responsible for a
third of admissions to the intensive care unit (ICU) and costs the
economy of the United States alone $17 billion annually (Angus
et al., 2001; Schmid et al., 2002; Longo et al., 2007). For patients
who do survive, many carry a substantial burden of continued
physical and psychological ill health, with return to work rates
below 65% (Bone et al., 1992; Schmid et al., 2002).
Large-scale surveillance studies have identified the most
common organisms implicated in sepsis (Opal and Cohen,
1999; Vincent et al., 2009). Although fungal and viral infections
contribute to many sepsis deaths, bacterial pathogens are the
most frequent causative agents, with Staphylococcus aureus
and Streptococcus pneumoniae representing the most relevant
Gram-positive species, and Escherichia coli, Klebsiella spp., and
Pseudomonas aeruginosa dominating the Gram-negative group
(Angus et al., 2001; Vincent et al., 2009). The relative contribution
by each of these different organism types is heavily influenced by
local population characteristics, organism virulence, and health
care structure variables.
The organism class responsible for the primary infection, has
been shown to play a role in determining the mortality of patients
with sepsis. In this study, these primary infections are termed
“first-hit” infections. However, there are conflicting findings
regarding the magnitude and the direction of the differences
between Gram-positive and Gram-negative infections (Vincent
et al., 2006; Labelle et al., 2012; Ani et al., 2015). The largest
of these studies (Ani et al., 2015), with over 5 million patient
records in the United States analyzed retrospectively, attributed a
mortality of 30.4% to sepsis caused by Gram-positive organisms
and 23.3% to Gram-negative organisms. However, the highest
mortality in this cohort was 36.3% in patients infected with
anaerobic Gram-negative microbes suggesting the importance of
further stratification according to organism types instead of solely
relying on Gram status.
With improving rates of initial survival in severe sepsis
(Vincent et al., 1995; Gaieski et al., 2010; McPherson et al.,
2013), nosocomial infections that occur following resolution
of the initial insult carry an increasing burden of morbidity
(Vincent et al., 1995; Agnese et al., 2002; Gaieski et al., 2010).
In this study these infections are termed second-hit infections
and include pathologies such as ventilator-associated pneumonia
and intravascular line infections as well as reactivation of latent
chronic viral infections such as cytomegalovirus (Vincent et al.,
2009). However, despite the clinical relevance of these infections,
there are no data available in the literature on differential
outcomes from Gram-positive pathogens compared with Gram-
negative species in patients with first and second-hit infections.
We here attempted to address this knowledge gap, using both
local data from a single hospital and data from a national audit
database in the United Kingdom.
MATERIALS AND METHODS
The design, management, and analysis of this observational
cohort study were conducted according to the principles declared
in The World Medical Association’s Declaration of Helsinki. All
data were analyzed anonymously, retrospectively, and did not
impact upon the clinical care of any patients.
The definitions of sepsis and systemic inflammatory response
syndrome (SIRS) were based on the 2012 Surviving Sepsis
Guidelines in place at that time (Dellinger et al., 2013). The local
data collection was approved by the South East Wales Research
Ethics Committee (reference number 10WSE/421, June 2011)
and registered with the UK Clinical Research Network (UKCRN;
Cellular and biochemical investigations in sepsis, ID 11231).
The national data were screened from all admissions to
NHS adult, general critical care units in England, Wales, and
Northern Ireland participating in the Case Mix Programme of
the Intensive Care National Audit & Research Centre (ICNARC)
Data Specification between 1 January 2007 and 30 June 2012.
An analysis plan was agreed a priori according to the following
definitions:
First-hit infection: patients admitted with a non-infective
diagnosis that subsequently developed an intensive care unit-
acquired infection in blood.
Second-hit infection: patients admitted with severe sepsis as an
initial diagnosis that subsequently developed an intensive care
unit-acquired infection in blood.
All patients were categorized into those that developed Gram-
positive or Gram-negative infection subtypes. Four specific
patient subgroups were chosen before analysis as the first-
hit cohort. These sub-groups were patients categorized as
having trauma, emergency neurosurgery, elective surgery, and
cardiogenic shock as their primary reason for intensive care
admission. It has been shown that these patients can provide
a plausible and accessible model of the development of severe
sepsis (Cain et al., 2015).
As described above, patients in the second-hit cohort were
admitted to the ICU with an initial diagnosis of severe sepsis,
and then subsequently developed an ICU-acquired infection in
blood. Thereafter, the same descriptive statistics and survival
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analyses were applied to patients with first-hit and second-hit
infections. Acute hospital mortality was defined as the status
at ultimate discharge from the acute hospital, excluding re-
admissions within the same hospital stay.
Themain organism causing the first-hit infection in blood was
defined as the presence of an infection in any blood sample taken
for microbiological culture 48 h or more following admission to
the intensive care unit. Similarly, second-hit infection in blood
was defined as the presence of infective bacteria in any blood
sample taken for microbiological culture 48 h or more following
admission to the intensive care unit in patients admitted with
severe sepsis as initial diagnosis. If two organisms were isolated
in both blood culture bottles, first organism priority was given
according to the following ranking used by ICNARC: Methicillin
resistant S. aureus (MRSA); S. aureus (not MRSA); vancomycin
resistant Enterococcus spp. (VRE); Enterococcus spp. (not VRE);
yeast (e.g., Candida spp.); Pseudomonas spp.; Acinetobacter spp.;
Enterobacter spp.; Klebsiella spp.; Serratia spp.; E. coli; or other
organisms entered using free text. The Gram classifications were
then specified from the organism reported as the main organism
causing first unit-acquired infection in blood.
The local dataset consisted of patients admitted with severe
sepsis to the intensive care unit (ICU) at The Royal Glamorgan
Hospital, Llantrisant, UK between 2010 and 2013 who were
retrospectively analyzed for 90-day all-cause mortality according
to the Gram status of the organism responsible for their initial
sepsis diagnosis. Due to the narrow limits of this data collection
restricted to electronically captured microbiological data and
outcome data only, it was not possible to propensity match
patients nor compare other cofounders such as age that may lead
to excessive mortality in one arm of this study.
Cumulative survival curves as a function of time were
generated using the Kaplan-Meier approach with censored
results indicating patient discharge and compared using the log-
rank test. Intergroup differences in baseline characteristics were
compared using a two-way ANOVA, unmatched and corrected
for multiple comparisons with a Sidak test using SPSS 20.0.
The funders had no role in study design, data collection,
data analysis, data interpretation, or writing of the report.
All authors had full access to all the data in the study
and share final responsibility for the decision to submit for
publication. The ICNARC data are available on request directly
to icnarc@icnarc.org.
RESULTS
Outcomes from First-Hit Infections
According to Local and National Datasets
The Kaplan-Meier curve shown in Figure 1A demonstrates that
when a Gram-negative organism was identified as the prime
cause of sepsis, patients had an excessive mortality rate of 29.1%
compared with 21.3% for those where a Gram-positive organism
was identified. This was equivalent to an odds ratio for death of
1.8 (1.18–2.73) in the Gram-negative subgroup.
In order to corroborate this relationship on a national
scale, ICNARC’s database of UK critical care units was used.
ICNARC records do not include the causative organisms
FIGURE 1 | Kaplan-Meier analysis of sepsis patient survival according
to Gram status of the causative organism. (A) Local dataset of first-hit
sepsis patients (n = 371). (B) ICNARC dataset of first-hit trauma patients
developing a unit-acquired infection (n = 703). (C) ICNARC dataset of first-hit
elective surgery patients developing a unit-acquired infection (n = 616). (D)
ICNARC dataset of second-hit sepsis patients subsequently developing a
unit-acquired infection (n = 2131). All Gram differences are significant using
the Mantel-Cox (Log-rank) test at p < 0.01.
responsible for admissions to ICU with severe sepsis. The
only recorded organism names are those responsible for “unit-
acquired infections” occurring after 48 hrs or more following
admission to ICU with alternative pathologies. We therefore
identified groups of patients admitted to ICUwithout an infective
etiology (trauma and elective surgery patients) to examine
clinical outcome differences following acquisition of a unit-
acquired infection that could act as a surrogate for first-hit
infection causing severe sepsis.
The baseline characteristics of these groups of first-hit patients
are shown in Table 1. While intergroup differences existed
between trauma and elective surgery patients, as expected, the
Gram-positive and Gram-negative groups within each cohort
showed no significant differences in baseline parameters. Despite
this similarity in morbidity, mortality rates showed striking
differences between the two groups. Importantly, the mortality
patterns in trauma (Figure 1B) and elective surgery patients
(Figure 1C) matched that of the local dataset (Figure 1A).
Mortality from Gram-negative infections in the trauma and
elective groups was 27.9 and 43.6%, respectively, compared
with 20.6 and 25.6% for Gram-positive infections. Overall,
this translated to an odds ratio for death of 1.4 and 1.7,
respectively, in trauma and elective surgery patients with Gram-
negative infections. No significant differences were found in
the mortality of patients with cardiogenic shock and those
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TABLE 1 | Baseline patient characteristics from the ICNARC dataset according to infecting organism type.
First-hit (trauma) First-hit (elective surgery) Second-hit
Gram + Gram − Gram + Gram − Gram + Gram −
Number of admissions % [N] 49.8 [353] 49.4 [350] 46.4 [308] 53.2 [308] 47.3 [1009] 52.1 [1110]
Age mean (sd) 48.6 (20.0) 49.5 (19.8) 64.4 (14.6) 67.6 (12.8) 61.9 (14.9) 61.6 (15.4)
Gender % male 77.9 74.9 69.2 76.8 60.5 59.4
Caucasian % 88.6 90.6 95.6 96.9 94.0 92.4
Liver condition in PMH % 1.1 1.1 2.0 4.0 48.6 47.8
Renal condition in PMH % 0.0 1.7 0.0 2.0 1.7 1.6
Respiratory condition in PMH % 0.6 0.6 1.0 4.0 48.4 47.5
Cardiovascular condition in PMH % 0.3 0.3 2.0 4.0 0.9 0.8
In- hospital CPR % 0.8 4.0 2.0 3.0 3.1 2.3
Community CPR % 0.0 2.0 0.0 0.0 0.3 0.4
No CPR % 97.2 94.0 98.3 97.9 96.6 97.3
ICNARC mean (sd) 19.4 (6.7) 20.9 (7.2) 18.2 (8.3) 17.8 (7.3) 25.2 (8.1) 25.5 (8.1)
APACHE II mean (sd) 14.5 (6.2) 14.9 (6.7) 16.5 (5.8) 16.2 (4.7) 20.4 (6.3) 20.3 (6.5)
Acute hospital mortality % 20.6 27.9** 25.6 43.6** 46.3 40.4**
There were no significant differences in these baseline characteristics between organism types within respective groups to explain the mortality differences observed by Gram-status.
The results were analyzed using a two-way ANOVA, unmatched and corrected for multiple comparisons with a Sidak test *p < 0.05; **p < 0.01; ***p < 0.001. PMH, past medical
history; CPR, cardiopulmonary resuscitation; APACHE, Acute Physiology And Chronic Health Evaluation.
undergoing emergency neurosurgery although the numbers in
these sub-groups were low (Supplementary Figure 1).
National Outcomes from Second-Hit
Infections
As ICNARC records unit-acquired organism names in different
cohorts of patient groups, it was possible to examine the
mortality in severe sepsis patients who develop a second-hit
infection. The baseline characteristics of these patients had no
statistical differences when using Gram status as a comparator
(Table 1). However, compared with first-hit infections, an inverse
relationship between Gram status and mortality was seen.
Second-hit infections in sepsis patients had a mortality of 40.4%
when a Gram-negative infection was responsible compared
with 43.6% when Gram-positive organisms were recorded
(Figure 1D). This resulted in an odds ratio for death of 0.8
following infection with Gram-negative pathogens in second-hit
infections.
DISCUSSION
The present analysis accords with previous studies showing
that first-hit infections caused by Gram-negative organisms
result in a greater mortality in sepsis compared with Gram-
positive pathogens (Ani et al., 2015). In striking contrast
to this pattern in primary infections, our findings are the
first to show that Gram-positive second-hit infections carry
a higher risk of death compared to infections caused by
Gram-negative pathogens. Of note, the national scale and
standardized reporting of the corresponding data provide a
significant advance in the analysis of differential outcomes in
well-defined subgroups of patients developing first-hit or second-
hit sepsis, that can now be addressed further in the clinic and
experimentally.
Although infection-related organ dysfunction continues to
be responsible for ∼30% of ICU admissions, there is a
surprising lack of comparative epidemiological data on the
recent trends of infective organisms. The largest such dataset
to-date, the EPIC II study, is almost 10 years old (Labelle
et al., 2012). In that study, the investigators found a larger
prevalence of Gram-negative infections and worse outcomes
associated with certain organisms, and observed a significant
relationship between time spent on the ICU and development
of infections, particularly those caused by methicillin-resistant
S. aureus (MRSA), Acinetobacter, and Pseudomonas species
(Labelle et al., 2012). A small-scale study from mainland China
recently confirmed this distribution of the infective organisms
(Agnese et al., 2002). Our present findings demonstrate that the
relative risk attributable to Gram-negative compared with Gram-
positive mortality may be as high as 1.7 for first-hit infections.
The underlying causes for these mortality differences are
likely to be multifactorial. Firstly, there may be logistical and
procedural reasons as to why these patients have an excessive
mortality. The increasing levels of multidrug-resistant Gram-
negative organisms (Dellinger et al., 2013; Cain et al., 2015) may
render patients with these causative organisms more likely to
receive ineffective initial therapy (Micek et al., 2012; Zilberberg
et al., 2014). However, recent data from the World Healthcare-
Associated Infections Forum indicates that multidrug-resistant
Gram-negative organisms only play a very small role in the UK
with incidences below 5%, making this explanation less plausible
(Leligdowicz et al., 2014).
Secondly, there may be unmeasured pathological differences
due to the epidemiology of different organisms. In fact, after
adjustments for organism class and type, the site of infection
appears to play a key role in differential patient survival (Vincent
et al., 2006; De Waele et al., 2014; Leligdowicz et al., 2014). With
the knowledge that patterns of microbial classes differ between
different infectious sources, simply basing a mortality prediction
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on an organism typemay act as a surrogate for the likely source of
infection. This may help explain some of the variation shown in
the literature comparing organism class and species. The extent of
variation shown in those studies exposes many of the difficulties
inherent in retrospective analysis of a syndrome characterized by
a number of individual disease entities across a hugely variable
cohort of patients. In conjunction with widely varying microbial
resistance patterns across different countries, the inconsistent
use and timing of appropriate antibiotics makes comparing
international results a difficult task and further highlights the
need for better quality data.
Thirdly, the differences in outcome between Gram-negative
and Gram-positive infections may represent a particular
predisposition of different patients to develop distinct types of
infections (Agnese et al., 2002; Escoll et al., 2003; Cavaillon and
Adib-Conquy, 2006; Porta et al., 2009; Lynn, 2014). What has
been observed in our study may simply be an excessive mortality
due to genetic and environmental differences rather than the
microorganisms directly. However, despite these possibilities, it
is undeniable that the Gram status can be used as a strong signal
to point toward an expected excessive mortality. This in itself is
important and useful.
Finally, there are clear immunological differences that
occur as a result of an organism’s structural and biochemical
characteristics. As a classical example, this may predominantly be
due to the presence of a lipopolysaccharide (LPS)-containing cell
wall in Gram-negative bacteria. LPS is recognized by a range of
cell types and promotes inflammation as well as acts as potent
inducer of the coagulation cascade (Mansur et al., 2014). In
addition to the presence of LPS as a major discriminator between
Gram-negative and Gram-positive bacteria, such mortality
differences seen here may also be influenced by other pathogen-
specific characteristics including the ability of most Gram-
negative organisms to activate innate-like Vγ9/Vδ2 T cells and
mucosal-associated invariant T (MAIT) cells (Davey et al., 2014;
Grimaldi et al., 2014). Individual organism pathogenicity will also
influence patient outcomes as much as the pharmacokinetics of
the drugs used to target such microbes. Therefore, more virulent
Gram-negative microbes may more rapidly replicate and have
higher toxin loads (Ramachandran, 2014).
What is more intriguing than the relationship between
Gram status and mortality from first-hit infection is the
apparent inverse relationship between mortality and Gram
status in sepsis patients who subsequently acquire a second-
hit infection. Again, this is likely to be multifactorial. There is
a wealth of immunological literature demonstrating profound
reprogramming effects on both cellular and humoral immunity
that severe sepsis leaves in its wake (Escoll et al., 2003; Cavaillon
and Adib-Conquy, 2006; Trusheim et al., 2007; Porta et al., 2009;
Hotchkiss et al., 2013; Davey et al., 2014; Lynn, 2014). These
tolerising effects may render survivors of first-hit infections more
resistant to subsequent Gram-negative sepsis. There may also be
organizational aspects to thesemortality differences including the
use of antimicrobials with adverse side effect profiles in Gram-
positive second-hit infections to cover the possibility of MRSA
infection. Furthermore, there may be a survival bias to these data.
For example, those patients who survive an initial Gram-negative
infection may have an inherent resistance to Gram-negative
infections. Therefore, these patients may bemore likely to survive
and subsequently develop second-hit infections, and the data
might thus, be skewed toward a survival benefit of Gram-negative
infection when these patients develop a second infection.
Several improvements could be made in future studies of
this topic. Firstly, microbiological data on true first-hit sepsis
patients were not available through ICNARC’s dataset. Therefore,
we defined surrogate first-hit infection subgroups including post-
operative elective surgery and trauma patients. There is a large
volume of research supporting the use of these groups of patients
as a model for investigating first-hit infection (Cain et al., 2015).
With the advent of new nation-wide systems of sepsis outcomes
such as the recording through the work of the UK Sepsis
Trust and the National Institute for Health and Care Excellence
(NICE), causative organism data may be possible to analyse in
the future. Indeed, new trial design may be a key component of
improving research in this area (Stevenson et al., 2014). Studies
should also aim to address the survival bias discussed above.
By recording the initial infecting organism responsible for the
first-hit sepsis, it should be possible to explore such relationships
further.
Secondly, although the ICNARC dataset has considerable
power due to its size and robust collection methods, it suffers
from lack of granular detail and a relatively arbitrary collection
priority of organisms. It would be important in future research to
record when and from where individual organisms are isolated.
The ranking of organisms allowing only a single species to be
recorded may bias data collection in favor of Gram-positive
infections that in turn may skew future analysis. The list of
organisms was based on data from the European Centre for
Disease Prevention and Control for the UK and has been shown
to be representative in independent datasets (Heginbothom et al.,
2013). Therefore, ICNARC outcome data have significant clinical
relevance in everyday practice. In addition to these possible
confounders, the disease severity scores in the present study were
recorded at the time of ICU admission, rather than at the time of
initial pathology (i.e., surgical procedure time point), and may
thus have diverged by the time of subsequent ICU admission.
Unfortunately, the ICNARC dataset is not able to compensate
for these factors. However, despite these methodical issues, they
remain constant in all groups studied and as such cannot account
for the reversal of mortality in first-hit compared with second-hit
infections. This is a clear signal being sent although the intricacies
of this detail will need to be addressed with a different future
methodology.
CONCLUSION
Overall, our study demonstrates that Gram-negative infections
are associated with a greatly elevated mortality in first-hit
sepsis patients whilst these differences are reversed in second-
hit infections. These findings will allow clinicians to better plan
and deliver care to the patients most at risk from severe sepsis by
targeting resources more effectively. It may also form a platform
to explore the immune reprogramming effects of sepsis ex vivo
by comparing subsequent responses from patients with differing
initial infection types.
Frontiers in Microbiology | www.frontiersin.org 5 February 2016 | Volume 7 | Article 207
Morgan et al. Differences of Outcome in Gram-Negative and Gram-Positive Sepsis
AUTHOR CONTRIBUTIONS
MM, KR, and ME designed the study. TS and PO abstracted the
local data. SP and KR abstracted the national data from the Case
Mix Programme. MM, SP, and KR directed and conducted the
data analysis. MM, TS, and ME wrote the paper. JH provided
expert advice and revised the draft. All authors read and approved
the final version.
FUNDING
Dr. TS reports grants from National Institute of Social and
Health Care Research, Welsh Assembly Government, UK,
during the conduct of the study. Dr. ME reports grants from
SARTRE/SEWAHSPHealth Technology Challenge and theMRC
Confidence in Concept scheme, during the conduct of the
study.
ACKNOWLEDGMENTS
The work described received support from the UK Clinical
Research Network Study Portfolio. TS was in receipt of a Clinical
Research Fellowship from the National Institute of Social and
Health Care Research (NISCHR).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fmicb.
2016.00207
Supplementary Figure 1 | Kaplan-Meier analysis of sepsis patient survival
according to Gram status of the causative organism. (A) ICNARC dataset of
first-hit emergency neurosurgical patients developing a unit-acquired infection
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